Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression (Q33362731)

26 July 2017

title

Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression (English)

1 reference

26 July 2017

0 references

1 reference

13

Toru Sugiyama

1 reference

26 July 2017

2

Hiroaki Itamochi

1 reference

26 July 2017

5

Tetsuro Oishi

1 reference

26 July 2017

7

Shinya Sato

1 reference

26 July 2017

6

Muneaki Shimada

1 reference

26 July 2017

12

Tasuku Harada

1 reference

26 July 2017

11

Hiroaki Komatsu

1 reference

26 July 2017

Seiya Sato

1

1 reference

26 July 2017

Nao Oumi

3

1 reference

26 July 2017

Youhei Chiba

4

1 reference

26 July 2017

Jun Chikumi

8

1 reference

26 July 2017

Michiko Nonaka

9

1 reference

26 July 2017

Akiko Kudoh

10

1 reference

26 July 2017

publication date

9 March 2016

1 reference

26 July 2017

1 reference

26 July 2017

volume

29

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

181-187

1 reference

describes a project that uses

26 July 2017

TU-OC-2

0 references

cites work

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Endometriosis and ovarian cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Chromatin remodelling during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

The spectrum of SWI/SNF mutations, ubiquitous in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Potential therapeutic targets in ARID1A-mutated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Epigenetic and genetic dispositions of ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Inhibition of the PI3K pathway: hope we can believe in?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0138-6

p53 mutation is infrequent in clear cell carcinoma of the ovary

21 January 2018

1 reference

12 December 2020

Differential drug sensitivity conferred by growth status detected in a mixed population of cycling and noncycling cells.

1 reference

12 December 2020

Clear cell carcinoma of the ovary.Light and electron microscopic studies

1 reference

12 December 2020

When mutants gain new powers: news from the mutant p53 field.

1 reference

12 December 2020

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

1 reference

12 December 2020

Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells

1 reference

12 December 2020

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

1 reference

12 December 2020

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

1 reference

12 December 2020

Prevalence of ovarian endometriosis in epithelial ovarian cancer

1 reference

12 December 2020

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

1 reference

12 December 2020

Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties

1 reference

12 December 2020

Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay

1 reference

12 December 2020

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

1 reference

12 December 2020

World Health Organization classification and nomenclature of ovarian cancer

1 reference

12 December 2020

10.1007/S13577-016-0138-6

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1020345115

0 references

1 reference